...
首页> 外文期刊>Turkish Journal of Hematology >Evaluation of Endocrine Late Complications in Childhood Acute Lymphoblastic Leukemia Survivors: A Report of a Single-Center Experience and Review of the Literature
【24h】

Evaluation of Endocrine Late Complications in Childhood Acute Lymphoblastic Leukemia Survivors: A Report of a Single-Center Experience and Review of the Literature

机译:儿童急性淋巴细胞白血病幸存者内分泌晚期并发症的评估:单中心经验的报告和文献综述。

获取原文
           

摘要

Objective: Improvement in long-term survival in patients with acutelymphoblastic leukemia (ALL) in childhood has led to the need formonitorization of treatment-related morbidity and mortality. Inthe current study, we aimed to evaluate endocrine side effects oftreatment in ALL survivors who were in remission for at least 2 years.Materials and Methods: Sixty patients diagnosed with ALL, whowere in remission for at least 2 years, were cross-sectionally evaluatedfor long-term endocrine complications.Results: The median age of the patients at the time of diagnosis,at the time of chemotherapy completion, and at the time of thestudy was 5 years (minimum-maximum: 1.7-13), 8 years (minimummaximum:4.25-16), and 11.7 years (minimum-maximum: 7-22),respectively, and median follow-up time was 4 years (minimummaximum:2-10.1). At least one complication was observed in 81.6%of patients. Vitamin D insufficiency/deficiency (46.6%), overweight/obesity (33.3%), and dyslipidemia (23.3%) were the three mostfrequent endocrine complications. Other complications seen in ourpatients were hyperparathyroidism secondary to vitamin D deficiency(15%), insulin resistance (11.7%), hypertension (8.3%), short stature(6.7%), thyroid function abnormality (5%), precocious puberty (3.3%),and decreased bone mineral density (1.7%). There were no statisticallysignificant correlations between endocrine complications and age, sex,and radiotherapy, except vitamin D insufficiency/deficiency, whichwas significantly more frequent in pubertal ALL survivors comparedto prepubertal ALL survivors (57.5% and 25%, respectively, p=0.011).Conclusion: A high frequency of endocrine complications wasobserved in the current study. The high frequency of late effectsnecessitates long-term surveillance of this population to betterunderstand the incidence of late-occurring events and the definingof high-risk features that can facilitate developing interventionstrategies for early detection and prevention.
机译:目的:儿童急性淋巴细胞白血病(ALL)患者长期生存的改善导致需要对与治疗相关的发病率和死亡率进行监测。在本研究中,我们旨在评估在缓解期至少2年的所有幸存者中治疗的内分泌副作用。材料与方法:60例在缓解期至少2年的确诊为ALL的患者经过长期横断面评估内分泌并发症。结果:诊断时,化疗完成时和研究之时的患者中位年龄为5岁(最低至最高:1.7-13岁),8岁(最低至最高年龄:随访时间分别为4.25-16)和11.7年(最短-最长:7-22),中位随访时间为4年(最短/最长:2-10.1)。 81.6%的患者中至少观察到一种并发症。维生素D不足/缺乏(46.6%),超重/肥胖(33.3%)和血脂异常(23.3%)是三种最常见的内分泌并发症。我们患者中观察到的其他并发症是维生素D缺乏引起的甲状旁腺功能亢进(15%),胰岛素抵抗(11.7%),高血压(8.3%),身材矮小(6.7%),甲状腺功能异常(5%),性早熟(3.3%) ),骨矿物质密度降低(1.7%)。内分泌并发症与年龄,性别和放疗之间无统计学意义的相关性,除了维生素D不足/缺乏,与青春期前的所有幸存者相比,青春期ALL的幸存者患病率明显更高(分别为57.5%和25%,p = 0.011)。 :在本研究中观察到内分泌并发症的频率很高。后期影响的频率很高,因此需要对该人群进行长期监测,以更好地了解后期事件的发生率,并定义高风险特征,以利于为早期发现和预防制定干预策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号